Each vial contains: GHK-Cu 50 mg BPC-157 10 mg TB-500 (Full Sequence Thymosin 4) 10 mg Together these peptides represent complementary areas of regenerative research, ranging from extracellular matrix biology and connective tissue physiology to cell migration and soft-tissue repair
The amylin pathway represents a fundamentally different approach than GLP-1 agonists, making it complementary rather than redundant
In summary, FOXO4-DRI exerts its anti-aging effects by inhibiting the binding of FOXO4 to P53, promoting P53 phosphorylation, and facilitating the translocation of p-P53 from the nucleus to the cytoplasm for its functional role
At 15 amino acids in length, BPC 157 is actually the largest of the three
A lot of early tests were conducted on rats, mice, chickens, and other animals, revealing potential benefits across different organs [3]